Stereotaxis was the first tenant in the (then) new Cortex district of St. Louis, and the scrappy medical device company is finally moving into it’s own digs — because its growth demanded it.
This company has more than 120 employees, a market cap near a half billion, and quarterly revenues in millions. Moving into the newly renovated lower floors of the historic Globe building in St. Louis attracted a couple hundred movers and shakers.
Caught Schmoozing:
- Marty McCabe, BoS; Kris Weidenbenner, BoS; Tony Depung, Reinhold Electric
- Jeff Tubb, The UP Companies; Paul Renaud, Square UP; Josh Knaust, Square UP
- John Deters, Dyno Manufacturing; Dale Ruthsatz, SLDC
- Rob Orr, SLDC; Emily Hemingway, TechSTL
- Mike Talcott, Stereotaxis; David Fischel, Stereotaxis CEO
- Bethanne Schluter, Stereotaxis; Sarah Smith, Community Development Ventures
- Mike Parson, Missouri; Neal Richardson, SLDC
- Dick Fleming, Community Development Ventures
SIDE NOTE:
In 2000 I started a publication called Business News Update, covering early stage tech startups. Stereotaxis was one of the startups I covered. Here’s a screen shot of a story from 2003 when the FDA approved use of one of their first products. I designed and built a content management system with what is now called a paywall and BNU may have been the first news organization anywhere to put content behind a paywall. I got a call from the Wall St. Journal when they were considering it, and they didn’t know anyone else doing that. The venture failed because of the huge costs associated with designing and building the technology, a lack of market validation for the product, robust competition by the (then) vibrant print publications in the area and mostly because people refused to pay for electronic content of any kind. All of those conditions have changed, and new opportunities in niche publishing exist, hence 4thEst8.
– Paul Riat, publisher
Stereotaxis BNU big
